Ge joined the Health Economics Group as a senior health economist in 2019. His research has a strong quantitative methodology basis and spans the field of applied microeconometrics, health economics, public health and statistical analysis of routinely collected health data.

Ge was trained as an economist at the Universities of Bristol and Bath before undertaking an ESRC postdoctoral fellowship at the University of Sheffield. He moved to the Institute for Health and Human Development, University of East London, where he was responsible for providing statistical support in the design and analysis of the RCT designed Well London programme and other projects. He subsequently worked as a health economist at the University of Leeds, working extensively on economic evaluations in the field of cardiovascular diseases, fractures of the low radius, and dental health care. In 2015, he moved to the Epidemiology and Cancer Statistics Group, University of York, working as a lead health economist/statistician. 

I am a member of the UK Health Economists' Study Group (HESG), the International Health Economics Association (iHEA), Trial Methodology Research Partnership (TMRP) health economics working group member, NCRI Screening, Prevention and Early Diagnosis (SPED) Advisory Group member, and NIHR Statistics Group Routine Data Section co-leader. 

Qualifications

• PhD Economics, University of Bath
• MSc Economics, University of Bristol
• MBA, University of Southampton
• BA (Hons) Economics, Zhejiang University

Area of expertise

• Applied microeconometrics
• Health economics
• Health technology assessment
• Economic evaluation

I would be interested to hear from prospective PhD students if they have research interests in any of these areas.

Google scholar: Click here

• Hoeks M, Yu G, Langemeijer S, Crouch S, De Swart L, Fenaux P, Symeonidis A, Čermák J, Hellström-Lindberg E, Sanz G, Stauder R, Skov Holm M, Mittelman M, Mądry K, Malcovati L, Tatic A, Medina Almeida A, Germing U, Savic A, Gredelj Šimec N, Culligan D, Itzykson R, Guerci-Bresler A, Slama B, van de Loosdrecht A, van Marrewijk C, Droste J, Blijlevens N, van Kraaij M, Bowen D, de Witte T, Smith A. Impact of treatment with iron chelation therapy in lower-risk MDS patients participating in the European LeukemiaNet MDS (EUMDS) Registry. Haematologica 2019, 104(12).
• Madry K, Yu G, Lis K, Fenaux P, Bowen D, Symeonidis A, Mittelman M, Stauder R, Cermak J, Sanz G, Hellström-Lindberg E, Malcovati L, Langemeijer S, Germing U, Holm MS, Guerci-Bresler A, Culligan D, Sanhes L, Mils J, Kotsianidis I, van Merrewijk C, Crouch S, de Witte TM, Smith A. Excess mortality in low-risk MDS can be explained by MDS and AML related causes of death. Blood 2018, 132(Suppl. 1), 4385.
• Stauder R, Yu G, Koinig KA, Bagguley T, Fenaux P, Symeonidis A, Sanz G, Mittelman M, Hellstrom-Lingberg E, Langemeijer S, Skov Holm M, Madry K, Malcovati L, Tatic A, Germing U, Savic A, van Merrewijk C, Guerci-Bresler A, Luno E, Droste J, Efficace F, Smith A, Bowen D, de Witte T. Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study. Leukemia 2018, 32, 1380-1392.
• Wang H, Manca A, Crouch S, Bagguley T, Yu G, Aas E, Smith A. Health-state utility values in diffuse large B-cell lymphoma. In: ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems. 2018, Barcelona: Elsevier Inc.
• Stauder R, Yu G, Koinig KA, Culligan D, Fenaux P, Cermak J, Langemeijer S. Longitudinal changes of impairments in health-related quality of life in low-risk MDS patients: a European Leukemianet study. In: 60th ASH Annual Meeting. 2018, San Diego, CA, USA: American Society of Hematology.
• Oster HS, Crouch S, Smith A, Yu G, Shrkihe BA, Baruch S, Kolomansky A, Ben-Ezra J, Naor S, Fenaux P, Symeonidis A, Stauder R, Cermak J, Sanz G, Hellstrom-Lindberg E, Malcovati L, Langemeijer S, Germing U, Holm MS, Madry K, Guerci-Bresler A, Culligan D, Sanhes L, Mills J, Kotsianidis I, van Marrewijk C, Bowen D, de Witte T, Mittelman M. MDS diagnosis: many patients may not require Bone Marrow Examination. In: 60th ASH Annual Meeting. 2018, San Diego, CA, USA: American Society of Hematology.
• Fu Y, Yu G, McNichol E, Marczewski K, Closs SJ. The association between patient-professional partnerships and self-management of chronic back pain: a mixed methods study. European Journal of Pain 2018, 22(7), 1229-1244.
• Oster HS, Shrkihe BA, Crouch S, Smith A, Yu G, Carmi G, Stauder R. Can we diagnose MDS without bone marrow examination? A proposed EUMDS-based non-invasive diagnostic model. In: 59th American Society of Hematology Annual Meeting. 2017, Atlanta GA: American Society of Hematology.
• Symeonidis A, Yu G, Smith A, Fenaux P, Mittelman M, Stauder R, Langemeijer S. The impact of diabetes mellitus as comorbid condition, in patients with lower-risk myelodysplastic syndromes (MDS) – a study of the European LeukemiaNet-based MDS (EUMDS) Registry. In: 59th American Society of Hematology Annual Meeting. 2017, Atlanta GA: American Society of Hematology.
• Wang H, Smith A, Yu G, Aas E, Bagguley T, Howell D, Patmore R. UK utility elicitation in patients with follicular lymphoma. In: ISPOR 20th Annual European Congress. 2017, Glasgow: Elsevier Inc.
• Fu Y, Yu G, McNichol E, Marczewski K, Closs SJ. The effects of patient-professional partnerships on the self-management and health outcomes for patients with chronic back pain: a quasi-experimental study. International Journal of Nursing Studies 2016, 59, 197-207.
• Yu G, Fu Y, Sessions JG, Wall M. A Multilevel Cross-Lagged Structural Equation Analysis for Reciprocal Relationship between Social Capital and Health. Social Science & Medicine 2015, 142, 1-8.
• Tubeuf S, Yu G, Achten J, Parsons NR, Rangan A, Lamb SE, Costa ML. Cost-effectiveness of treatment with percutaneous Kirschner wires versus volar lacking plate for adult patients with a dorsally displaced fracture of the distal radius: Analysis from the DRAFFT trial. Bone and Joint Journal 2015, 97-B(8), 1082-1089.
• Phillips G, Bottomley C, Schmidt E, Tobi P, Lais S, Yu G, Clow A. Well London Phase-1: results among adults of a cluster-randomised trial of a community engagement approach to improving health behaviours and mental well-being in deprived inner-city neighbourhoods. Journal of Epidemiology and Community Health 2014, 68, 606-614.
• Hulme C, Yu G, Browne C, ODwyer J, Craddock H, Brown S, Dukanovic G. Cost-effectiveness of silicone and alginate impressions for complete dentures. Journal of Dentistry 2014, 42(8), 902-907.
• Phillips G, Bottomley C, Schmidt E, Tobi P, Lais S, Yu G, Clow A. Measures of exposure to the Well London Phase-1 intervention and their association with health well-being and social outcomes. Journal of Epidemiology and Community Health 2014, 68(7), 597-605.
• Watts P, Phillips G, Petticrew M, Hayes R, Bottomley C, Yu G, Lock K. Physical activity in deprived communities in London: Examining individual and neighbourhood-level factors. PLoS One 2013.
• Cresswell JA, Yu G, Hatheral B, Morris J, Jamal F, Harden A, Renton A. Predictors of the timing of initiation of antenatal care in an ethnically diverse urban cohort in the UK. BMC Pregnancy and Childbirth 2013.
• Bertotti M, Watts P, Netuveli G, Yu G, Schmidt E, Tobi P, Renton A. Types of social capital and mental disorder in deprived urban areas: A multilevel study of 40 disadvantaged London neighbourhoods. PLoS One 2013.
• Phillips G, Hayes R, Bottomley C, Petticrew M, Watts P, Lock K, Yu G, Tobi P. OP06 Well London: Results of a cluster-randomised trial of a community development approach to improving health behaviours and mental wellbing in deprived inner-city neighbourhoods. Journal of Epidemiology & Community Health 2012.
• Phillips G, Renton A, Moore DG, Bottomley C, Schmidt E, Lais S, Yu G, Clow A. The Well London program – a cluster randomized trial of community engagement of improving health behaviors and mental wellbeing: baseline survey results. Trials 2012.
• Renton A, Phillips G, Daykin N, Yu G, Taylor K, Petticrew M. Think of your art-eries: arts participation, behavioural cardiovascular risk factors and mental wellbeing in deprived communities in London. Public Health 2012, 126, S57-S64.
• Tobi P, Estacio EV, Yu G, Renton A, Foster N. Who stays, who drops out? Biosocial predictors of adherence in participants attending a longer term exercise referral scheme in the UK10.1186/1471-2458-12-347. BMC Public Health 2012.
• Yu G, Renton A, Schmidt E, Tobi P, Bertotti M, Watts P, Lais S. A multilevel analysis of the association between social networks and support on leisure time physical activity: Evidence from 40 disadvantaged areas in London. Health & Place 2011, 17(5), 1023-1029.
• Phillips G, Watts P, Petticrew M, Lock K, Hayes R, Bottomley C, Yu G, Clow A. Determinants of mental health and wellbeing in low income communities: A multilevel approach examining individual and neighbourhood characteristics. Journal of Epidemiology & Community Health 2011.
• Watts P, Phillips G, Petticrew M, Hayes R, Bottomley C, Yu G, Renton A. Determinants of physical activity in deprived communities in London: Examining the effects of individual and neighbourhood characteristics. Journal of Epidemiology & Community Health 2011.
• Yu G, Renton A, Wall M, Estacio E, Cawley J, Datta P. Prevalence of low physical activity and its relation to social environment in deprived areas in the London Borough of Redbridge. Social Indicators Research 2011, 104, 311-322.